Suppr超能文献

血清 IGF-1 水平升高足以维持正常的体型和骨骼特征,即使在组织 IGF-1 缺乏的情况下也是如此。

Elevated serum levels of IGF-1 are sufficient to establish normal body size and skeletal properties even in the absence of tissue IGF-1.

机构信息

Division of Endocrinology, Diabetes and Bone Disease, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.

出版信息

J Bone Miner Res. 2010 Jun;25(6):1257-66. doi: 10.1002/jbmr.20.

Abstract

Use of recombinant insulin-like growth factor 1 (IGF-1) as a treatment for primary IGF-1 deficiency in children has become increasingly common. When untreated, primary IGF-1 deficiency may lead to a range of metabolic disorders, including lipid abnormalities, insulin resistance, and decreased bone density. To date, results of this therapy are considered encouraging; however, our understanding of the role played by IGF-1 during development remains limited. Studies on long-term treatment with recombinant IGF-1 in both children and animals are few. Here, we used two novel transgenic mouse strains to test the long-term effects of elevated circulating IGF-1 on body size and skeletal development. Overexpression of the rat igf1 transgene in livers of mice with otherwise normal IGF-1 expression (HIT mice) resulted in approximately threefold increases in serum IGF-1 levels throughout growth, as well as greater body mass and enhanced skeletal size, architecture, and mechanical properties. When the igf1 transgene was overexpressed in livers of igf1 null mice (KO-HIT), the comparably elevated serum IGF-1 failed to overcome growth and skeletal deficiencies during neonatal and early postnatal growth. However, between 4 and 16 weeks of age, increased serum IGF-1 fully compensated for the absence of locally produced IGF-1 because body weights and lengths of KO-HIT mice became comparable with controls. Furthermore, micro-computed tomography (microCT) analysis revealed that early deficits in skeletal structure of KO-HIT mice were restored to control levels by adulthood. Our data indicate that in the absence of tissue igf1 gene expression, maintaining long-term elevations in serum IGF-1 is sufficient to establish normal body size, body composition, and both skeletal architecture and mechanical function.

摘要

使用重组胰岛素样生长因子 1(IGF-1)治疗儿童原发性 IGF-1 缺乏症已变得越来越普遍。未经治疗,原发性 IGF-1 缺乏症可能导致一系列代谢紊乱,包括脂质异常、胰岛素抵抗和骨密度降低。迄今为止,这种治疗的结果被认为是令人鼓舞的;然而,我们对 IGF-1 在发育过程中所起作用的理解仍然有限。关于重组 IGF-1 在儿童和动物中的长期治疗的研究很少。在这里,我们使用两种新型转基因小鼠品系来测试循环 IGF-1 升高对体型和骨骼发育的长期影响。在 otherwise normal IGF-1 表达的小鼠(HIT 小鼠)肝脏中过表达大鼠 igf1 转基因,导致整个生长过程中血清 IGF-1 水平增加约三倍,体重增加,骨骼增大,结构和机械性能增强。当 igf1 转基因在 igf1 缺失型小鼠(KO-HIT)的肝脏中过表达时,可比的升高的血清 IGF-1 未能克服新生儿和早期产后生长中的生长和骨骼缺陷。然而,在 4 至 16 周龄之间,升高的血清 IGF-1 完全补偿了局部产生的 IGF-1 的缺乏,因为 KO-HIT 小鼠的体重和长度变得与对照组相当。此外,微计算机断层扫描(microCT)分析表明,KO-HIT 小鼠骨骼结构的早期缺陷在成年时恢复到对照水平。我们的数据表明,在没有组织 igf1 基因表达的情况下,维持血清 IGF-1 的长期升高足以建立正常的体型、身体成分以及骨骼结构和机械功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e0/3153133/698053d7e52c/jbmr0025-1257-f1.jpg

相似文献

引用本文的文献

2
A genetic model for proximity labelling of the mammalian secretome.
Open Biol. 2022 Aug;12(8):220149. doi: 10.1098/rsob.220149. Epub 2022 Aug 10.
4
Postnatal expression of is the norm in amniote vertebrates.
Proc Biol Sci. 2022 Feb 23;289(1969):20212278. doi: 10.1098/rspb.2021.2278.
5
Macrophage-Specific IGF-1 Overexpression Reduces CXCL12 Chemokine Levels and Suppresses Atherosclerotic Burden in Apoe-Deficient Mice.
Arterioscler Thromb Vasc Biol. 2022 Feb;42(2):113-126. doi: 10.1161/ATVBAHA.121.316090. Epub 2021 Dec 2.
6
Mice with gene alterations in the GH and IGF family.
Pituitary. 2022 Feb;25(1):1-51. doi: 10.1007/s11102-021-01191-y. Epub 2021 Nov 19.
8
9
Effects of GH/IGF axis on bone and cartilage.
Mol Cell Endocrinol. 2021 Jan 1;519:111052. doi: 10.1016/j.mce.2020.111052. Epub 2020 Oct 14.
10
New Surgical Model for Bone-Muscle Injury Reveals Age and Gender-Related Healing Patterns in the 5 Lipoxygenase (5LO) Knockout Mouse.
Front Endocrinol (Lausanne). 2020 Aug 11;11:484. doi: 10.3389/fendo.2020.00484. eCollection 2020.

本文引用的文献

1
Elevated levels of insulin-like growth factor (IGF)-I in serum rescue the severe growth retardation of IGF-I null mice.
Endocrinology. 2009 Sep;150(9):4395-403. doi: 10.1210/en.2009-0272. Epub 2009 Jun 4.
2
4
The hormonal action of IGF1 in postnatal mouse growth.
Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19378-83. doi: 10.1073/pnas.0809223105. Epub 2008 Nov 25.
8
Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling.
Bone. 2006 Sep;39(3):494-504. doi: 10.1016/j.bone.2006.02.068. Epub 2006 Apr 27.
9
Insulin-like growth factor binding proteins in development.
Adv Exp Med Biol. 2005;567:55-89. doi: 10.1007/0-387-26274-1_3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验